바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.59 No.3
Citation Share

Implication of embB Gene Mutation in Ethambutol-Susceptible Clinical Isolates of Mycobacterium tuberculosis

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2005, v.59 no.3, pp.266-271









Sonya Shin (Brigham and Women's Hospital)
& Sonya, S. (2005). Implication of embB Gene Mutation in Ethambutol-Susceptible Clinical Isolates of Mycobacterium tuberculosis. Tuberculosis & Respiratory Diseases, 59(3), 266-271.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background : Ethambutol(EMB) is one of the first-line drugs included in short-course anti-tuberculosis therapy. The point mutations in embB gene have been speculated to be associated EMB resistance. However, detection of embB mutations at these positions have been observed in both EMB-susceptible isolates; thus, it remains controversial whether these mutations are associated with EMB resistance Methods : The 36 M. tuberculosis isolates were selected from clinical isolates which tested susceptible to EMB and resistant to at least one drug. DNA extracted from the isolates was analyzed by amplifying embB gene. The PCR products were purified and directly sequenced. We reviewed the history of past drug susceptibility test results. Results : Out of 36 EMB-susceptible strains, 3 strains (8.3%) had a mutation in codon 306 or 406 of the embB gene. These three strains had at least isoniazid resistance. They grew at 1.0 mcg/ml of EMB in Lowenstein-Jensen media. The patients of the strains were continuously smear-positive for over 3 years despite taking TB therapy. One strain had been EMB-resistant in past drug susceptibility tests. Conclusion : EMB-susceptible strains containing embB mutation may be caused by decreased viability in vitro test not by itself. (Tuberc Respir Dis 2005; 59: 266-271)

keywords
embB gene, Mutation, Ethambutol, Mycobacterium tuberculosis, Drug resistance, Korea, embB gene, Mutation, Ethambutol, Mycobacterium tuberculosis, Drug resistance, Korea

Reference

1.

(amrevrespirdis1961) The in vitro activity of ethambutol,

2.

(1989) Inhibition of synthesis of arabinogalactanby ethambutol in Mycobacterium smegmatis,

3.

(1997) The emb operon,a genecluster of Mycobacterium tuberculosis involved in resistance toethambutol,

4.

(1997) Role of embB in natural andacquired resistance to ethambutol in mycobacteria,

5.

(2000) Molecular genetic analysisof nucleotide polymorphisms associated with ethambutol resistancein human isolates of Mycobacterium tuberculosis,

6.

(1997) Ethambutol resistance inMycobacterium tuberculosis:critical role of embB mutations,

7.

(2004) Novel mutation within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis,

8.

(2002) Detection ofembB306 mutations in ethambutol-susceptible clinical isolates ofMycobacterium tuberculosis from northwestern Russia:implicationsfor genotypic resistance testing,

9.

(1997) Drug resistant tuberculosis in Korea,1994,

10.

(1993) Strain identification of Mycobacterium tuberculosis by DNA fingerprinting:recommendations for a standardized methodology,

11.

(2001) Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high- incidence community,

12.

(2005) Detection of embB gene mutation of Mycobacterium tuberculosis by reverse hybridization,

13.

(2001) The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg→Leu mutation at codon 463 of katG are not associated,

Tuberculosis & Respiratory Diseases

e-Submission OA Policy